Metabolytic Research is a seed-stage startup developing long-acting subcutaneous therapy to treat type 3c, or pancreatogenic, diabetes mellitus (T3cDM). T3cDM is characterized by severe, erratic, difficult-to-control, swings in glycemia and episodes of deadly severe hypoglycemia. Our first-of-any-kind therapy addresses a huge unmet need as there are no therapeutics available to meet the unique, complex challenges of T3cDM.
Company Details
- Employees
- 1
- Founded
- 2023
- Address
- Santa Fe, Nm, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://metabolytic.com
- Keywords
- Cambridge.
- HQ
- Santa Fe, NM
Metabolytic Research Questions
Metabolytic Research's website is https://metabolytic.com
Metabolytic Research's LinkedIn profile is https://www.linkedin.com/company/metabolytic-research
Metabolytic Research has
1 employees.
View email and phone details for 1
employees at Metabolytic Research.
Metabolytic Research's industry is
Biotechnology Research
Metabolytic Research's top competitors are
Innsightful,
Impact Recycling,
Phyteau, Inc.,
Okaya,
Fascia Sleep,
Fascia,
Envoya Inc.,
Diawiser,
Startup Santa Fe,
Labcycle.
Metabolytic Research's categories are Biotechnology Research
Metabolytic Research's founding year is 2023
